Universitair Verplegingscentrum Brugmann, Frans: Centre Hospitalier Universitaire Brugmann, is een academisch ziekenhuis in Brussel. Op 16 juni 1923 werd het ziekenhuis officieel ingehuldigd. Het is ontstaan uit een legaat van filantroop Georges Brugmann.

During the past decade, CHU Brugmann conducted 177 clinical trials. In the 10-year time frame, 177 clinical trials started and 19 clinical trials were completed, i.e. on average, 10.7% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 13 clinical trials were completed. i.e. 18.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Brugmann" #1 sponsor was "Brugmann University Hospital" with 86 trials, followed by "Pierre Wauthy" with 11 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials sponsored, "Murielle Surquin" with 7 trials sponsored and "Amgen" with 7 trials sponsored. Other sponsors include 102 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Brugmann" #1 collaborator was "Centre Hospitalier Universitaire Brugmann" with 4 trials as a collaborator, "Erasme University Hospital" with 3 trials as a collaborator, "UNICANCER" with 3 trials as a collaborator, "Université Libre de Bruxelles" with 3 trials as a collaborator and "Breast International Group" with 2 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "CHU Brugmann" are "Sickle Cell Disease" (10 trials), "Breast Cancer" (8 trials), "Covid19" (7 trials), "Sarcopenia" (6 trials) and "Atrial Fibrillation" (4 trials). Many other conditions were trialed in "CHU Brugmann" in a lesser frequency.

Most popular intervention types in "CHU Brugmann" are "Drug" (73 trials), "Other" (64 trials), "Device" (38 trials), "Procedure" (24 trials) and "Diagnostic Test" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Data extraction from medical files" (14 trials), "Blood sampling" (6 trials), "Questionnaire" (5 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "CHU Brugmann" are 187 trials for "All" genders, 34 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "CHU Brugmann". 2 are not yet recruiting, 26 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 150 completed trials in CHU Brugmann, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Brugmann, 4 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 66 trials that are defined as “Not Applicable".

CHU Brugmann has several departments that took part in Clinical trials: "CHU Brugmann (site V Horta) Service de néphrologie" - 4 trials